Published in Science on February 03, 1978
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proc Natl Acad Sci U S A (1979) 1.63
Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br J Cancer (1978) 1.60
Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J Exp Med (1979) 1.51
Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. Immunology (1987) 1.37
Cyclic nucleotide-induced maturation of human promyelocytic leukemia cells. J Clin Invest (1982) 1.37
Macrophage activation, chronic inflammation and gastrointestinal disease. Gut (1984) 1.27
Regulation of colony-stimulating activity production. Interactions of fibroblasts, mononuclear phagocytes, and lactoferrin. J Clin Invest (1983) 1.25
Relationship of prostaglandin secretion by rabbit alveolar macrophages to phagocytosis and lysosomal enzyme release. Biochem J (1979) 1.23
In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood (2009) 1.18
Prostaglandin E inhibition of T-lymphocyte colony formation: a possible mechanism of monocyte modulation of clonal expansion. J Clin Invest (1979) 1.18
Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity. J Clin Invest (1982) 1.12
Association between colony forming units-granulocyte macrophage expression of Ia-like (HLA-DR) antigen and control of granulocyte and macrophage production. A new role for prostaglandin E. J Clin Invest (1982) 1.04
Prostaglandin regulation of colony-stimulating factor production by lipopolysaccharide-stimulated murine leukocytes. Infect Immun (1979) 1.04
Nature and mechanisms of action of co-operating cells controlling human T-colony formation. Immunology (1982) 1.04
sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells. J Clin Invest (1987) 1.04
Macrophage growth arrest by cyclic AMP defines a distinct checkpoint in the mid-G1 stage of the cell cycle and overrides constitutive c-myc expression. Mol Cell Biol (1992) 0.96
Common pattern of two distinct types of colony-stimulating factor in human tissues and cultured cells. J Clin Invest (1980) 0.96
Macrophages: progress and problems. Clin Exp Immunol (1981) 0.85
Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins. J Clin Invest (1980) 0.85
Rapid transcriptional down-regulation of c-myc expression during cyclic adenosine monophosphate-promoted differentiation of leukemic cells. J Clin Invest (1987) 0.84
Prostaglandin biosynthesis in pulmonary macrophages. Am J Pathol (1979) 0.81
Inhibition of mouse peritoneal macrophage DNA synthesis by infection with the arenavirus Pichinde. Infect Immun (1984) 0.81
Cyclic nucleotides and phosphodiesterases in monocytic differentiation. Handb Exp Pharmacol (2011) 0.79
Inhibitory effect of a human T cell hybrid factor on both cell growth and mixed lymphocyte reactivity. Correlation with class II molecule expression. J Clin Invest (1985) 0.79
Effect of age on immune function in terms of chemically induced cancers. Environ Health Perspect (1979) 0.77
Regulation of the colony-stimulating activity produced by a murine marrow-derived cell line (H-1). Proc Natl Acad Sci U S A (1982) 0.75
Rabbit lymphocyte factors modulate prostaglandin biosynthesis in alveolar macrophages. Immunology (1985) 0.75
Treatment of a case of fulminant hepatic failure with continuous infusion of prostaglandin (PGE1). Korean J Intern Med (1988) 0.75
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med (2001) 9.53
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest (1997) 7.58
Evidence for circulating bone marrow-derived endothelial cells. Blood (1998) 6.15
A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity (1996) 5.64
Vitamin D and bisphosphonate response. Osteoporos Int (2014) 5.04
Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol (1970) 4.32
Experimental studies on the development of the thymus. J Exp Med (1967) 3.94
Comparative study of diagnostic procedures for congenital cytomegalovirus infection. Pediatrics (1980) 3.53
Production of Shiga-like toxin by Escherichia coli. J Infect Dis (1986) 3.53
Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood (1980) 3.51
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49
Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med (1978) 3.38
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 3.30
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med (2001) 3.25
A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content. J Natl Cancer Inst (1969) 3.06
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci U S A (1985) 3.02
Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood (2001) 3.01
Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A (1977) 2.80
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med (1997) 2.79
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood (1992) 2.77
Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med (1996) 2.71
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Differentiation (1997) 2.58
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol (1993) 2.47
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med (1988) 2.40
Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (1995) 2.40
Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol (1999) 2.34
Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. Cytokine (1995) 2.34
Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol (2001) 2.28
Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes. J Exp Med (1984) 2.26
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22
Colony formation in vitro by myelomonocytic leukemic cells. J Natl Cancer Inst (1969) 2.21
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med (1987) 2.17
Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA (1998) 2.16
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med (1997) 2.12
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest (2000) 2.08
Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest (2000) 2.05
Long-term in vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique. J Immunol (1981) 1.99
Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. J Immunol (1988) 1.97
Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production. J Exp Med (1978) 1.94
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood (1995) 1.94
Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood (1998) 1.93
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood (1994) 1.90
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci U S A (2001) 1.90
Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol (1983) 1.88
Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol (1997) 1.87
Growth of B-lymphocytes clones in semisolid culture is mitogen dependent. J Exp Med (1976) 1.86
Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells. Proc Natl Acad Sci U S A (1985) 1.83
Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF. J Immunol (1981) 1.71
Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci (1997) 1.71
Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood (1995) 1.69
The fate of fetal and adult B-cell progenitors grafted into immunodeficient CBA/N mice. J Exp Med (1979) 1.68
Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res (1997) 1.68
Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors. J Exp Med (1977) 1.67
Chromosome marker studies on the development of the haemopoietic system in the chick embryo. Nature (1965) 1.66
In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells. J Natl Cancer Inst (1973) 1.65
Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics. Blood (1974) 1.64
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proc Natl Acad Sci U S A (1979) 1.63
Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood (1996) 1.63
Differentiation of mouse bone marrow precursor cells into neutrophil granulocytes by an activity separation from WEHI-3 cell-conditioned medium. Differentiation (1978) 1.61
CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol (1998) 1.60
Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. Blood (1993) 1.58
Role of stem cell migration in initiation of mouse foetal liver haemopoiesis. Nature (1975) 1.56
Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol (1992) 1.56
Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun (1999) 1.56
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med (1987) 1.55
SCID mice as an in vivo model of human cord blood hematopoiesis. Blood Cells (1994) 1.54
Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood (1997) 1.52
Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J Exp Med (1979) 1.51
Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity. J Exp Med (1982) 1.50
Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells. Mol Cell Biol (1998) 1.50
Embryonic origin of the mouse macrophage. Blood (1972) 1.47
Hematopoietic defects in mice lacking the sialomucin CD34. Blood (1996) 1.46
Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation. Exp Hematol (2001) 1.45
Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester. Cell Immunol (1982) 1.44
Cloning and characterization of exodus, a novel beta-chemokine. Blood (1997) 1.44
Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency. J Clin Immunol (1984) 1.44
Mzf1 controls cell proliferation and tumorigenesis. Genes Dev (2001) 1.43
Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med (1998) 1.43
Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood (1998) 1.42
Experimental studies on the development of the bursa of Fabricius. Dev Biol (1966) 1.41
Inducible production of human macrophage growth factor, CSF-1. Blood (1986) 1.40
Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J Exp Med (2000) 1.38
Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J Exp Med (1985) 1.37